Torpedo Therapeutics Analysis
What is Torpedo Therapeutics?
Torpedo Therapeutics develops high-precision, closed-loop deep brain stimulation therapy for neurological disorders. The company says its electrodes are 150 times smaller than existing DBS lead electrodes and pairs them with an electronic chip for readout and stimulation control. It also describes a machine-learning data analysis platform that adjusts stimulation parameters using sensed neural activity.
Location
Boston, United States
Employees
1-10
Founded
2018
Investors
- Y Combinator
Product Features & Capabilities
- High-precision deep brain stimulation therapy, closed-loop sensing and stimulation, automated data analysis platform, implantable neuromodulation devices for neurological disorders.
Who are the founders of Torpedo Therapeutics
IV
Ingrid van Welie
Founder and CEO
Market Focus
Torpedo Therapeutics primarily focuses on the healthcare industry, specifically in the field of neurology, with an emphasis on developing high-precision, closed-loop deep brain stimulation therapies for treating neurological disorders.
Competitors Overview
The main competitors of Torpedo Therapeutics in the deep brain stimulation (DBS) market include:
-
Medtronic: A pioneer in the DBS field, Medtronic offers a range of devices for treating neurological disorders, including Parkinson's disease and epilepsy. Their systems are known for their reliability and extensive clinical data supporting their use.
-
Boston Scientific: This company provides advanced DBS systems that are designed to be less invasive and offer features like rechargeable batteries. Boston Scientific emphasizes patient comfort and ease of use in their devices.
-
Abbott Laboratories: Abbott has developed innovative DBS systems that focus on personalized therapy options. Their devices are designed to adapt to the patient's needs, providing a tailored approach to treatment.
Notable differences and advantages:
- Medtronic is recognized for its extensive experience and comprehensive clinical studies backing its products.
- Boston Scientific focuses on user-friendly designs and rechargeable options, which can reduce long-term costs for patients.
- Abbott emphasizes personalized treatment, which may enhance patient outcomes by adapting therapy to individual needs.
These companies have established themselves as leaders in the neuromodulation market, each with unique strengths that differentiate them from Torpedo Therapeutics.
See something that needs updating? Suggest edits to this profile.